![Steve Cartt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steve Cartt
Director/Board Member at
Neurelis, Inc.
Profile
Stephen Lahue Cartt is currently a Director at Neurelis, Inc. He was previously a Director at Lineage Cell Therapeutics, Inc., a Senior Director-Strategic Marketing at Elan Pharmaceuticals, LLC, a Director at Asterias Biotherapeutics, Inc., a Director at TXP Pharma AG (Switzerland), a Principal at ALZA Corp., the Chief Operating Officer at Questcor Pharmaceuticals, Inc., and the COO-Autoimmune & Rare Diseases Business Unit at Mallinckrodt Plc.
He holds an MBA from Santa Clara University and an undergraduate degree from the University of California, Davis.
Steve Cartt active positions
| Companies | Position | Start |
|---|---|---|
Neurelis, Inc.
 Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes product candidates for the treatment of central nervous system disorders | Director/Board Member | 2019-12-31 |
Former positions of Steve Cartt
| Companies | Position | End |
|---|---|---|
TXP Pharma AG (Switzerland)
 TXP Pharma AG (Switzerland) Pharmaceuticals: MajorHealth Technology Engages in researching and developing pharmaceutical drugs for the treatment of autoimmune and inflammatory diseases | Director/Board Member | 2022-12-31 |
| ASTERIAS BIOTHERAPEUTICS INC | Chief Executive Officer | 2017-06-24 |
| LINEAGE CELL THERAPEUTICS, INC. | Director/Board Member | 2016-02-27 |
| MALLINCKRODT PLC | Corporate Officer/Principal | 2014-09-30 |
| QUESTCOR PHARMACEUTICALS INC | Chief Operating Officer | 2014-07-31 |
Training of Steve Cartt
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
65
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology Provides and develops pharmaceutical products | Health Technology |
Lineage Cell Therapeutics, Inc.
 Lineage Cell Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of therapeutic products for retinal & neurological diseases and disorders and oncology | Health Technology |
Questcor Pharmaceuticals, Inc.
 Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, markets and sells prescription drugs | Health Technology |
Elan Pharmaceuticals LLC
 Elan Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Keenova Therapeutics Plc
 Keenova Therapeutics Plc BiotechnologyHealth Technology Develops therapeutics for rheumatology, ophthalmology, nephrology, neurology, pulmonology, orthopedics, urology and neonatal respiratory problems | Health Technology |
Asterias Biotherapeutics, Inc.
 Asterias Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops and commercializes regenerative medicine for neurology and oncology applications | Health Technology |
Santa Clara University
 Santa Clara University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Davis
 University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neurelis, Inc.
Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes product candidates for the treatment of central nervous system disorders | Health Technology |
TXP Pharma AG (Switzerland)
TXP Pharma AG (Switzerland) Pharmaceuticals: MajorHealth Technology Engages in researching and developing pharmaceutical drugs for the treatment of autoimmune and inflammatory diseases | Health Technology |
- Stock Market
- Insiders
- Steve Cartt
